Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel de Paz

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Cancer|November 23, 2006
Darbepoetin alpha for the treatment of anemia in patients with myelodysplastic syndromesPilar Giraldo, Benet Nomdedeu, Javier Loscertales, et al.
Annals of Hematology|December 18, 2014
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complicationsÁngel F Remacha, Beatriz Arrizabalaga, Ana Villegas, et al.
British Journal of Clinical Pharmacology|March 8, 2014
Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaeniaMaria Teresa Álvarez Román, Ihosvany Fernández Bello, Elena G Arias-Salgado, et al.
American Journal of Hematology|June 4, 2014
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndromeGuillermo Garcia-Manero, Gary Gartenberg, David P Steensma, et al.
Cytometry. Part B, Clinical Cytometry|October 30, 2013
Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patientsJorge Monserrat, Miguel Ángel Sánchez, Raquel de Paz, et al.
Cytometry. Part B, Clinical Cytometry|July 31, 2013
Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patientsJorge Monserrat, Miguel Angel Sánchez, Raquel de Paz, et al.
Blood Reviews|March 6, 2026
Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemiaDennis Dong Hwan Kim, Daniela Zackova, Massimo Breccia, et al.
Frontiers in Immunology|October 26, 2019
GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS ProdigyLucía Fernández, Adrián Fernández, Isabel Mirones, et al.
International Journal of Hematology|March 27, 2021
Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseasesMercedes Gasior Kabat, David Bueno, Luisa Sisinni, et al.
Transfusion|March 16, 2018
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?Lucía Fernández, Alejandra Leivas, Jaime Valentín, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Cancer|November 23, 2006
Darbepoetin alpha for the treatment of anemia in patients with myelodysplastic syndromesPilar Giraldo, Benet Nomdedeu, Javier Loscertales, et al.
Annals of Hematology|December 18, 2014
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complicationsÁngel F Remacha, Beatriz Arrizabalaga, Ana Villegas, et al.
British Journal of Clinical Pharmacology|March 8, 2014
Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaeniaMaria Teresa Álvarez Román, Ihosvany Fernández Bello, Elena G Arias-Salgado, et al.
American Journal of Hematology|June 4, 2014
A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndromeGuillermo Garcia-Manero, Gary Gartenberg, David P Steensma, et al.
Cytometry. Part B, Clinical Cytometry|October 30, 2013
Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patientsJorge Monserrat, Miguel Ángel Sánchez, Raquel de Paz, et al.
Cytometry. Part B, Clinical Cytometry|July 31, 2013
Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patientsJorge Monserrat, Miguel Angel Sánchez, Raquel de Paz, et al.
Blood Reviews|March 6, 2026
Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemiaDennis Dong Hwan Kim, Daniela Zackova, Massimo Breccia, et al.
Frontiers in Immunology|October 26, 2019
GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS ProdigyLucía Fernández, Adrián Fernández, Isabel Mirones, et al.
International Journal of Hematology|March 27, 2021
Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseasesMercedes Gasior Kabat, David Bueno, Luisa Sisinni, et al.
Transfusion|March 16, 2018
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?Lucía Fernández, Alejandra Leivas, Jaime Valentín, et al.
Pageof 7